Details of Drug

Drug General Information (ID: D0036)
Drug Name	Alfuzosin
Drug Type	Small molecule
Drug Synonymous	Alfusosine; Alfuzosina; Alfuzosine; Alfuzosinum; Alphuzosine; Alfuzosina [Spanish]; Alfuzosine [French]; Alfuzosinum [Latin]; Alfuzosin (INN); Alfuzosin [INN:BAN]; Xatral (TN); N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide; N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide; N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamide Click to Show/Hide
Disease Class	GA90: Prostate hyperplasia
Therapeutic Class	Antihypertensive Agents
Structure
Structure	3D Structure		2D Structure
Formula	C19H27N5O4
InChI	1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)
InChIKey	WNMJYKCGWZFFKR-UHFFFAOYSA-N
Canonical SMILES	CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC
External Link
	Pubchem ID	2092
	CAS Number	81403-80-7
	CHEBI ID	51141
	TTD ID	D09MWJ
	VARIDT ID	DR01382

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM038 Additive CNS depression effects BM042 Additive hypotensive effects BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias BM089 Antagonize the effect of antihypertensive agents BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Alfuzosin
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 42
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0080		Amprenavir	C25H35N3O6S	65016	Major		Inter Info	[2], [3], [15], [16], [17]
D0116		Atazanavir	C38H52N6O7	148192	Major		Inter Info	[2], [3], [15], [16], [17]
D0192		Boceprevir	C27H45N5O5	10324367	Major		Inter Info	[2], [21]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[2], [3], [15], [16], [17]
D0375		Cobicistat	C40H53N7O5S2	25151504	Major		Inter Info	[2], [3], [15], [16], [17]
D0439		Delavirdine	C22H28N6O3S	5625	Major		Inter Info	[2], [3], [15], [16], [17]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Major		Inter Info	[2], [3], [15], [16], [17]
D0789		Idelalisib	C22H18FN7O	11625818	Major		Inter Info	[2], [3], [15], [16], [17]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Major		Inter Info	[2], [3], [15], [16], [17]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Major		Inter Info	[2], [3], [15], [16], [17]
D1117		Nefazodone	C25H32ClN5O2	4449	Major		Inter Info	[2], [3], [15], [16], [17]
D1315		Posaconazole	C37H42F2N8O4	468595	Major		Inter Info	[2], [3], [15], [16], [17]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[1], [2], [3], [109], [17], [110], [13]
D1415		Ritonavir	C37H48N6O5S2	392622	Major		Inter Info	[2], [3], [15], [16], [17]
D1541		Telaprevir	C36H53N7O6	3010818	Major		Inter Info	[2], [3], [15], [16], [17]
D1544		Telithromycin	C43H65N5O10	3002190	Major		Inter Info	[2], [3], [15], [16], [17]
D1653		Troleandomycin	C41H67NO15	202225	Major		Inter Info	[2], [3], [15], [16], [17]
D1660		Tucatinib	C26H24N8O2	51039094	Major		Inter Info	[2], [3], [15], [16], [17]
D1706		Voriconazole	C16H14F3N5O	71616	Major		Inter Info	[2], [3], [15], [16], [17]
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[2], [3], [15], [16], [17]
D0799		Indinavir	C36H47N5O4	5362440	Major		Inter Info	[2], [3], [15], [16], [17]
D1119		Nelfinavir	C32H45N3O4S	64143	Major		Inter Info	[2], [3], [15], [16], [17]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[150]
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[17]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[17]
D0386		Conivaptan	C32H26N4O2	151171	Moderate		Inter Info	[17]
D0413		Dalfopristin	C34H50N4O9S	6323289	Moderate		Inter Info	[17]
D0416		Danazol	C22H27NO2	28417	Moderate		Inter Info	[17]
D0432		Deferasirox	C21H15N3O4	214348	Moderate		Inter Info	[220], [221]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[17]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[17]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[17]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[237]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[17]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[17]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[258]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[2], [3], [259]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[17]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[17]
D0367		Clotrimazole	C22H17ClN2	2812	Moderate		Inter Info	[17]
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[17]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[17], [326], [327]
	CYP450 enzyme induction					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[3], [219]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[2], [228]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[234]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[275]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[3], [293]
D1401		Rifapentine	C47H64N4O12	135403821	Moderate		Inter Info	[305], [306]
D0106		Armodafinil	C15H15NO2S	9690109	Minor		Inter Info	[331], [332], [333], [334], [335]
D1081		Modafinil	C15H15NO2S	4236	Minor		Inter Info	[331], [332], [333], [334], [335]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[222]
D1172		Olopatadine (nasal)	C21H23NO3	5281071	Moderate		Inter Info	[283], [284], [285]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[320]
	Additive hypotensive effects					Drug Num: 157
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0010		Acebutolol	C18H28N2O4	1978	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D0045		Alprazolam	C17H13ClN4	2118	Moderate		Inter Info	[165], [166], [167]
D0055		Amifostine	C5H15N2O3PS	2141	Moderate		Inter Info	[168], [155], [169]
D0098		Apraclonidine	C9H10Cl2N4	2216	Moderate		Inter Info	[170], [171], [172]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D0128		Avanafil	C23H26ClN7O3	9869929	Moderate		Inter Info	[213], [214]
D0156		Benazepril	C24H28N2O5	5362124	Moderate		Inter Info	[215], [155]
D0158		Bendroflumethiazide	C15H14F3N3O4S2	2315	Moderate		Inter Info	[216], [154], [155]
D0161		Benzhydrocodone	C25H25NO4	49836084	Moderate		Inter Info	[165], [166], [167]
D0166		Benzthiazide	C15H14ClN3O4S3	2343	Moderate		Inter Info	[216], [154], [155]
D0188		Bisoprolol	C18H31NO4	2405	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D0202		Brexpiprazole	C25H27N3O2S	11978813	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D0206		Brimonidine (topical)	C11H10BrN5	2435	Moderate		Inter Info	[170], [171], [172]
D0222		Buspirone	C21H31N5O2	2477	Moderate		Inter Info	[165], [166], [167]
D0226		Butorphanol	C21H29NO2	5361092	Moderate		Inter Info	[165], [166], [167]
D0245		Canagliflozin	C24H25FO5S	24812758	Moderate		Inter Info	[2], [3], [217]
D0254		Captopril	C9H15NO3S	44093	Moderate		Inter Info	[215], [155]
D0262		Cariprazine	C21H32Cl2N4O	11154555	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D0263		Carisoprodol	C12H24N2O4	2576	Moderate		Inter Info	[165], [166], [167]
D0265		Carteolol	C16H24N2O3	2583	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D0266		Carteolol (ophthalmic)	C16H24N2O3	2583	Moderate		Inter Info	[151], [153], [155]
D0267		Carvedilol	C24H26N2O4	2585	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D0311		Chloral hydrate	C2H3Cl3O2	2707	Moderate		Inter Info	[165], [166], [167]
D0318		Chlormezanone	C11H12ClNO3S	2717	Moderate		Inter Info	[165], [166], [167]
D0321		Chlorothiazide	C7H6ClN3O4S2	2720	Moderate		Inter Info	[216], [154], [155]
D0322		Chlorphenesin	C9H11ClO3	7697	Moderate		Inter Info	[165], [166], [167]
D0327		Chlorzoxazone	C7H4ClNO2	2733	Moderate		Inter Info	[165], [166], [167]
D0356		Clobazam	C16H13ClN2O2	2789	Moderate		Inter Info	[165], [166], [167]
D0362		Clonazepam	C15H10ClN3O3	2802	Moderate		Inter Info	[165], [166], [167]
D0365		Clorazepic acid	C16H11ClN2O3	2809	Moderate		Inter Info	[165], [166], [167]
D0398		Cyclobenzaprine	C20H21N	2895	Moderate		Inter Info	[165], [166], [167]
D0418		Dapagliflozin	C21H25ClO6	9887712	Moderate		Inter Info	[2], [3], [217]
D0459		Dexmedetomidine	C13H16N2	5311068	Moderate		Inter Info	[2], [223], [224]
D0470		Dezocine	C16H23NO	3033053	Moderate		Inter Info	[165], [166], [167]
D0471		Diamorphine	C21H23NO5	5462328	Moderate		Inter Info	[165], [166], [167]
D0475		Dichloralphenazone	C15H18Cl6N2O5	10188	Moderate		Inter Info	[165], [166], [167]
D0493		Dihydrocodeine	C18H23NO3	5284543	Moderate		Inter Info	[165], [166], [167]
D0498		Dimenhydrinate	C24H28ClN5O3	10660	Moderate		Inter Info	[165], [166], [167]
D0502		Diphenhydramine	C17H21NO	3100	Moderate		Inter Info	[165], [166], [167]
D0524		Doxazosin	C23H25N5O5	3157	Moderate		Inter Info	[17]
D0533		Dronabinol	C21H30O2	16078	Moderate		Inter Info	[165], [166], [167]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[2], [3], [217]
D0567		Enalapril	C20H28N2O5	5388962	Moderate		Inter Info	[215], [155]
D0586		Epoprostenol	C20H32O5	5282411	Moderate		Inter Info	[3], [231], [232]
D0617		Ethanol	C2H6O	702	Moderate		Inter Info	[155], [233]
D0644		Fenoldopam	C16H16ClNO3	3341	Moderate		Inter Info	[155], [236]
D0646		Fentanyl	C22H28N2O	3345	Moderate		Inter Info	[165], [166], [167]
D0695		Fosinopril	C30H46NO7P	55891	Moderate		Inter Info	[215], [155]
D0745		Guanfacine	C9H9Cl2N3O	3519	Moderate		Inter Info	[2], [3], [244]
D0748		Halazepam	C17H12ClF3N2O	31640	Moderate		Inter Info	[165], [166], [167]
D0771		Hydrochlorothiazide	C7H8ClN3O4S2	3639	Moderate		Inter Info	[216], [154], [155]
D0772		Hydrocodone	C18H21NO3	5284569	Moderate		Inter Info	[165], [166], [167]
D0775		Hydroflumethiazide	C8H8F3N3O4S2	3647	Moderate		Inter Info	[216], [154], [155]
D0792		Iloprost	C22H32O4	5311181	Moderate		Inter Info	[3], [231], [232]
D0798		Indapamide	C16H16ClN3O3S	3702	Moderate		Inter Info	[216], [154], [155]
D0853		Isocarboxazid	C12H13N3O2	3759	Moderate		Inter Info	[246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [155], [256], [257]
D0884		Labetalol	C19H24N2O3	3869	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D0914		Levobetaxolol (ophthalmic)	C18H29NO3	60657	Moderate		Inter Info	[151], [153], [155]
D0915		Levobunolol (ophthalmic)	C17H25NO3	39468	Moderate		Inter Info	[151], [153], [155]
D0918		Levodopa	C9H11NO4	6047	Moderate		Inter Info	[168], [260], [261]
D0923		Levorphanol	C17H23NO	5359272	Moderate		Inter Info	[165], [166], [167]
D0933		Linezolid	C16H20FN3O4	441401	Moderate		Inter Info	[246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [155], [256], [257]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[165], [166], [167]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[1], [2], [3], [272], [13]
D0957		Loxapine	C18H18ClN3O	3964	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D0959		Lumateperone	C24H28FN3O	21302490	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D0980		Maraviroc	C29H41F2N5O	3002977	Moderate		Inter Info	[276]
D1001		Meperidine	C15H21NO2	4058	Moderate		Inter Info	[165], [166], [167]
D1005		Meprobamate	C9H18N2O4	4064	Moderate		Inter Info	[165], [166], [167]
D1006		Mepyramine	C17H23N3O	4992	Moderate		Inter Info	[165], [166], [167]
D1014		Metaxalone	C12H15NO3	15459	Moderate		Inter Info	[165], [166], [167]
D1019		Methdilazine	C18H20N2S	14677	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D1023		Methocarbamol	C11H15NO5	4107	Moderate		Inter Info	[165], [166], [167]
D1040		Methylphenobarbital	C13H14N2O3	8271	Moderate		Inter Info	[165], [166], [167]
D1045		Metipranolol (ophthalmic)	C17H27NO4	31477	Moderate		Inter Info	[151], [153], [155]
D1048		Metolazone	C16H16ClN3O3S	4170	Moderate		Inter Info	[216], [154], [155]
D1060		Midazolam	C18H13ClFN3	4192	Moderate		Inter Info	[165], [166], [167]
D1848		Minoxidil (topical)	C9H15N5O	4201	Moderate		Inter Info	[277], [278]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[165], [166], [167]
D1082		Moexipril	C27H34N2O7	91270	Moderate		Inter Info	[215], [155]
D1084		Molindone	C16H24N2O2	23897	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D1096		Nabilone	C24H36O3	5284592	Moderate		Inter Info	[165], [166], [167]
D1098		Nadolol	C17H27NO4	39147	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D1100		Nalbuphine	C21H27NO4	5311304	Moderate		Inter Info	[165], [166], [167]
D1114		Nebivolol	C22H25F2NO4	71301	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[154], [155], [279]
D1148		Nitrous acid	HNO2	24529	Moderate		Inter Info	[280], [281], [282]
D1183		Opium	NA	NA	Moderate		Inter Info	[165], [166], [167]
D1188		Orphenadrine	C18H23NO	4601	Moderate		Inter Info	[165], [166], [167]
D1197		Oxazepam	C15H11ClN2O2	4616	Moderate		Inter Info	[165], [166], [167]
D1203		Oxycodone	C18H21NO4	5284603	Moderate		Inter Info	[165], [166], [167]
D1208		Oxymorphone	C17H19NO4	5284604	Moderate		Inter Info	[165], [166], [167]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[205], [142], [208]
D1224		Paraldehyde	C6H12O3	31264	Moderate		Inter Info	[165], [166], [167]
D1244		Penbutolol	C18H29NO2	37464	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D1247		Pentazocine	C19H27NO	441278	Moderate		Inter Info	[165], [166], [167]
D1251		Pentoxifylline	C13H18N4O3	4740	Moderate		Inter Info	[287]
D1256		Perindopril	C19H32N2O5	107807	Moderate		Inter Info	[215], [155]
D1263		Phenelzine	C8H12N2	3675	Moderate		Inter Info	[246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [155], [256], [257]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[165], [166], [167]
D1267		Phenoxybenzamine	C18H22ClNO	4768	Moderate		Inter Info	[17]
D1271		Phentolamine	C17H19N3O	5775	Moderate		Inter Info	[17]
D1293		Pindolol	C14H20N2O2	4828	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D1311		Polythiazide	C11H13ClF3N3O4S3	4870	Moderate		Inter Info	[216], [154], [155]
D1331		Prazosin	C19H21N5O4	4893	Moderate		Inter Info	[17]
D1345		Procarbazine	C12H19N3O	4915	Moderate		Inter Info	[246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [155], [256], [257]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D1355		Propiomazine	C20H24N2OS	4940	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D1357		Propranolol	C16H21NO2	4946	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D1367		Quazepam	C17H11ClF4N2S	4999	Moderate		Inter Info	[165], [166], [167]
D1369		Quinapril	C25H30N2O5	54892	Moderate		Inter Info	[215], [155]
D1385		Rasagiline	C12H13N	3052776	Moderate		Inter Info	[246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [155], [256], [257]
D1390		Remifentanil	C20H28N2O5	60815	Moderate		Inter Info	[165], [166], [167]
D1391		Remimazolam	C21H19BrN4O2	9867812	Moderate		Inter Info	[165], [166], [167]
D1408		Riociguat	C20H19FN8O2	11304743	Moderate		Inter Info	[307]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[205], [142], [208]
D1437		Safinamide	C17H19FN2O2	131682	Moderate		Inter Info	[246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [155], [256], [257]
D1453		Secobarbital	C12H18N2O3	5193	Moderate		Inter Info	[165], [166], [167]
D1455		Selegiline	C13H17N	26757	Moderate		Inter Info	[246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [155], [256], [257]
D1457		Selexipag	C26H32N4O4S	9913767	Moderate		Inter Info	[3], [231], [232]
D1466		Silodosin	C25H32F3N3O4	5312125	Moderate		Inter Info	[17]
D1485		Sodium oxybate	C4H7NaO3	23663870	Moderate		Inter Info	[165], [166], [167]
D1527		Tadalafil	C22H19N3O4	110635	Moderate		Inter Info	[3], [309], [310]
D1534		Tamsulosin	C20H28N2O5S	129211	Moderate		Inter Info	[17]
D1552		Terazosin	C19H25N5O4	5401	Moderate		Inter Info	[17]
D1576		Thiothixene	C23H29N3O2S2	941651	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D1585		Timolol	C13H24N4O3S	33624	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D1586		Timolol (ophthalmic)	C13H24N4O3S	33624	Moderate		Inter Info	[151], [153], [155]
D1596		Tizanidine	C9H8ClN5S	5487	Moderate		Inter Info	[17], [313]
D1602		Tolazoline	C10H12N2	5504	Moderate		Inter Info	[17]
D1618		Trandolapril	C24H34N2O5	5484727	Moderate		Inter Info	[215], [155]
D1620		Tranylcypromine	C9H11N	19493	Moderate		Inter Info	[246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [155], [256], [257]
D1625		Treprostinil	C23H34O5	6918140	Moderate		Inter Info	[3], [231], [232]
D1632		Triazolam	C17H12Cl2N4	5556	Moderate		Inter Info	[165], [166], [167]
D1633		Trichlormethiazide	C8H8Cl3N3O4S2	5560	Moderate		Inter Info	[216], [154], [155]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[280], [281], [321]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[322], [323], [324]
D1729		Zolpidem	C19H21N3O	5732	Moderate		Inter Info	[165], [166], [167]
D0117		Atenolol	C14H22N2O3	2249	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D0143		Baclofen	C10H12ClNO2	2284	Moderate		Inter Info	[165], [166], [167]
D0173		Betaxolol	C18H29NO3	2369	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D0174		Betaxolol (ophthalmic)	C18H29NO3	2369	Moderate		Inter Info	[151], [153], [155]
D0224		Butabarbital	C10H16N2O3	2479	Moderate		Inter Info	[165], [166], [167]
D0225		Butalbital	C11H16N2O3	2481	Moderate		Inter Info	[165], [166], [167]
D0326		Chlorthalidone	C14H11ClN2O4S	2732	Moderate		Inter Info	[216], [154], [155]
D0379		Codeine	C18H21NO3	5284371	Moderate		Inter Info	[165], [166], [167]
D0602		Esmolol	C16H25NO4	59768	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D0776		Hydromorphone	C17H19NO3	5284570	Moderate		Inter Info	[165], [166], [167]
D0951		Lorazepam	C15H10Cl2N2O2	3958	Moderate		Inter Info	[165], [166], [167]
D1049		Metoprolol	C15H25NO3	4171	Moderate		Inter Info	[151], [152], [153], [154], [155], [156], [157], [158]
D1089		Morphine	C17H19NO3	5288826	Moderate		Inter Info	[165], [166], [167]
D1090		Morphine (liposomal)	C17H19NO3	5288826	Moderate		Inter Info	[165], [166], [167]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[203], [204], [205], [206], [45], [142], [207], [208], [209], [210], [211]
D1248		Pentobarbital	C11H18N2O3	4737	Moderate		Inter Info	[165], [166], [167]
D1379		Ramipril	C23H32N2O5	5362129	Moderate		Inter Info	[215], [155]
D1547		Temazepam	C16H13ClN2O2	5391	Moderate		Inter Info	[165], [166], [167]
D0711		Garlic	NA	NA	Minor		Inter Info	[336], [337]
	Increased risk of prolong QT interval					Drug Num: 146
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[14]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[20]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[3], [22]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[23], [3], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[1], [2], [3], [42], [43], [44]
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[1], [2], [3], [45], [13]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[46]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[1], [2], [3], [47]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[1], [2], [3], [48]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[49]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[1], [50], [2], [3], [51], [52], [13]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[55], [56], [57], [1], [2], [3], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[78], [1], [2], [3], [79], [80], [81], [82], [83]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[1], [2], [3], [84], [85], [86], [87], [88], [89], [13]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[23], [3], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[1], [2], [3], [90], [13]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[91]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[92]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[3], [93], [13]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[1], [2], [3], [94], [13]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[95]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[97]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[98], [99], [100], [101], [102], [103], [104], [105]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[1], [2], [3], [106]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[3], [107], [108], [13]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[111], [112], [1], [2], [3], [113], [114]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[3], [115]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[56], [1], [2], [3], [116], [117], [60], [62], [64], [118], [65], [66], [119], [68], [69], [70], [71], [120], [75], [121], [122]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[1], [2], [3], [123], [107], [124], [125], [126], [13]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[1], [2], [3], [15]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[1], [2], [3], [127]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[1], [2], [3], [128]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[1], [2], [3], [129]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[1], [2], [3], [130]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[1], [2], [3], [131]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[1], [2], [3], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [13]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[55], [56], [57], [1], [2], [3], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[1], [2], [3], [107], [142], [13]
D0003		Abarelix	C72H95ClN14O14	16131215	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[1], [17], [13]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[1], [2], [3], [212], [13]
D0115		Astemizole	C28H31FN4O	2247	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[3], [110]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[218]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[1], [17], [13]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[1], [17], [13]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0526		Doxepin (topical)	C19H21NO	667477	Moderate		Inter Info	[1], [17], [13]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Moderate		Inter Info	[1], [17], [13]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[229]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[2], [3], [230]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[2], [3], [235]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0682		Flutamide	C11H11F3N2O3	3397	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[56], [64], [65], [70], [239]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[240]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[241]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[3], [245]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[56], [1], [2], [3], [60], [61], [62], [262], [263], [65], [66], [264], [67], [265], [68], [69], [70], [71], [266], [267], [268], [75], [121]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[3]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[273], [274]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[56], [1], [2], [3], [60], [61], [62], [262], [263], [65], [66], [264], [67], [265], [68], [69], [70], [71], [266], [267], [268], [75], [121]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[3], [286]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[288], [289]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[292]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1342		Probucol	C31H48O2S2	4912	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[294], [295], [296], [297], [298], [299], [300], [301], [302], [303]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[1], [2], [3], [308]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[1], [2], [3], [311], [13]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[314], [315], [316], [317], [318], [319], [13]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1651		Triptorelin	C64H82N18O13	25074470	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[1], [2], [3], [17], [13]
D0737		Goserelin	C59H84N18O14	5311128	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D0908		Leuprolide	C59H84N16O12	657181	Moderate		Inter Info	[3], [143], [144], [145], [146], [147], [148], [149]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[329], [330]
D1555		Terfenadine	C32H41NO2	5405	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[1], [2], [3], [17], [13]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[2], [338], [339], [340]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[1], [2], [3], [341], [342], [343], [344]
	Increased risk of ventricular arrhythmias					Drug Num: 33
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[18], [19]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[1], [2], [3], [53], [54]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[96]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[1], [159], [2], [3], [160], [161], [162], [42], [163], [164]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[1], [2], [3], [225], [226], [227]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[2], [3], [238]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[1], [2], [3], [242], [243], [238]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[186], [196], [199]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[1], [2], [3], [242], [243], [238]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[1], [2], [3], [242], [243], [238]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[186], [196], [199]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[1], [2], [3], [242], [243], [238]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[1], [2], [3], [242], [243], [238]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[186], [196], [199]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[1], [2], [3], [242], [243], [238]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[3], [290], [291]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[3], [290], [291]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[2], [3], [238]
D1414		Ritodrine	C17H21NO3	33572	Moderate		Inter Info	[173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[1], [2], [3], [225], [226], [227]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[186], [196], [199]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[3], [290], [291]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[1], [2], [3], [225], [226], [227]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[2], [3], [312]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[186], [196], [199]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antihypertensive agents					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0926		Licorice	C42H62O16Zn	163463	Moderate		Inter Info	[269], [270], [271]
D1363		Pseudoephedrine	C10H15NO	7028	Moderate		Inter Info	[2], [3], [304]
D1061		Midodrine	C12H18N2O4	4195	Moderate		Inter Info	[3], [328], [155]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1691		Verteporfin	C82H84N8O16	11980904	Moderate		Inter Info	[325], [155]

References
1	Canadian Pharmacists Association.
2	Cerner Multum, Inc. "Australian Product Information.".
3	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
5	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
6	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
7	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
8	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
9	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
10	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
11	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
12	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
13	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
14	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
15	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
16	Product Information. Sporanox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
17	Product Information. Uroxatral (alfuzosin). sanofi-aventis , Bridgewater, NJ.
18	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
19	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
20	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
21	Product Information. Victrelis (boceprevir). Schering-Plough Corporation, Kenilworth, NJ.
22	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
23	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
24	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
25	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
26	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
27	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
28	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
29	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
30	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
31	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
32	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
33	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
34	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
35	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
36	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
37	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
38	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
39	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
40	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
41	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
42	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
43	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
44	Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251. [PMID: 10084425]
45	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
46	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
47	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
48	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
49	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
50	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
51	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
52	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
53	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
54	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
55	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
56	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
57	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
58	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
59	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
60	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
61	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
62	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
63	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
64	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
65	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
66	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
67	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
68	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
69	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
70	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
71	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
72	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
73	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
74	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
75	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
76	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
77	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
78	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
79	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
80	Nosten F, ter Kuile FO, Luxemburger C, et al "Cardiac effects of antimalarial treatment with halofantrine." Lancet 341 (1993): 1054-6. [PMID: 8096959]
81	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
82	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
83	Sudden death in a traveler following halofantrine administration--Togo, 2000. MMWR Morb Mortal Wkly Rep 50 (2001): 169-70, 179. [PMID: 11393488]
84	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
85	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
86	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
87	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
88	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
89	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
90	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
91	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
92	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
93	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
94	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
95	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
96	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
97	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
98	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
99	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
100	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
101	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
102	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
103	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
104	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
105	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
106	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
107	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
108	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
109	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
110	Abbas R, Hug BA, Leister C, Sonnichsen D "A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects." Int J Cancer 131 (2012): Epub. [PMID: 22065400]
111	Anson BD, Weaver JG, Ackerman MJ, et al. "Blockade of HERG channels by HIV protease inhibitors." Lancet 365 (2005): 682-686. [PMID: 15721475]
112	Biondi L "Health Canada endorsed important safety information on Invirase (saquinavir mesylate)." .
113	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
114	FDA. U.S. Food and Drug Administration "FDA drug safety communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms.".
115	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
116	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
117	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
118	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
119	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
120	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
121	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
122	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
123	Fletcher GF, Kazamias TM "Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias." Am Heart J 78 (1969): 135-8. [PMID: 5794785]
124	Hartigan-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SHL "Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans." Clin Pharmacol Ther 60 (1996): 543-53. [PMID: 8941027]
125	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
126	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
127	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
128	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
129	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
130	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
131	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
132	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
133	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
134	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
135	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
136	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
137	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
138	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
139	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
140	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
141	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
142	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
143	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
144	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
145	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
146	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
147	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
148	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
149	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
150	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
151	Chrysant SG "Experience with terazosin administered in combination with other antihypertensive agents." Am J Med 80 (1986): 55-61. [PMID: 2872808]
152	Elliott HL, McLean K, Sumner DJ, Meredith PA, Reid JL "Immediate cardiovascular responses to oral prazosin: effects of concurrent beta-blockers." Clin Pharmacol Ther 29 (1981): 303-9. [PMID: 6110503]
153	Holtzman JL, Kaihlanen PM, Rider JA, Lewin AJ, Spindler JS, Oberlin JA "Concomitant administration of terazosin and atenolol for the treatment of essential hypertension." Arch Intern Med 148 (1988): 539-43. [PMID: 3277569]
154	Pool JL "Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials." Am Heart J 122 (1991): 926-31. [PMID: 1678924]
155	Product Information. Xatral (alfuzosin). Sanofi-Synthelabo Canada Inc, Markham, ON.
156	Rubin P, Jackson G, Blaschke T "Studies on the clinical pharmacology of prazosin II: the influence of indomethacin and of propranolol on the action and disposition of prazosin." Br J Clin Pharmacol 10 (1980): 33-9. [PMID: 7397054]
157	Seideman P, Grahnen A, Haglund K, Lindstrom B, Von Bahr C "Prazosin first dose phenomenon during combined treatment with a B-adrenoceptor blocker in hypertensive patients." Br J Clin Pharmacol 13 (1982): 865-70. [PMID: 7093116]
158	Stokes GS, Mennie BA, Gellatly R, Hill A "On the combination of alpha- and beta-adrenoceptor blockade in hypertension." Clin Pharmacol Ther 34 (1983): 576-82. [PMID: 6627819]
159	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
160	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
161	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
162	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
163	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
164	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
165	Ellison JM, Milofsky JE, Ely E "Fluoxetine-induced bradycardia and syncope in two patients." J Clin Psychiatry 51 (1990): 385-6. [PMID: 2211552]
166	Feder R "Bradycardia and syncope induced by fluoxetine." J Clin Psychiatry 52 (1991): 139. [PMID: 2005082]
167	Sternbach H "Fluoxetine-associated potentiation of calcium-channel blockers." J Clin Psychopharmacol 11 (1991): 390-1. [PMID: 1770159]
168	Bailey DG, Dresser GK "Natural products and adverse drug interactions." Can Med Assoc J 170 (2004): 1531-2. [PMID: 15136542]
169	Product Information. Ethyol (amifostine). Alza, Palo Alto, CA.
170	Product Information. Alphagan (brimonidine ophthalmic). Allergan Inc, Irvine, CA.
171	Product Information. Mirvaso (brimonidine topical). Galderma Laboratories Inc, Cranbury, NJ.
172	Walters TR "Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies." Surv Ophthalmol 41 ( Suppl (1996): s19-26
173	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
174	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
175	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
176	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
177	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
178	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
179	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
180	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
181	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
182	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
183	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
184	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
185	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
186	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
187	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
188	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
189	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
190	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
191	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
192	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
193	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
194	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
195	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
196	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
197	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
198	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
199	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
200	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
201	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
202	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
203	Aronowitz JS, Chakos MH, Safferman AZ, Lieberman JA "Syncope associated with the combination of clozapine and enalapril." J Clin Psychopharmacol 14 (1994): 429-30. [PMID: 7884028]
204	Fruncillo R, Gibbons W, Vlasses P, Ferguson R "Severe hypotension associated with concurrent clonidine and antipsychotic medication." Am J Psychiatry 142 (1985): 274. [PMID: 2857531]
205	Markowitz JS, Wells BG, Carson WH "Interactions between antipsychotic and antihypertensive drugs." Ann Pharmacother 29 (1995): 603-9. [PMID: 7663034]
206	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
207	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
208	Product Information. Risperdal (risperidone). Janssen Pharmaceutica, Titusville, NJ.
209	Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
210	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
211	White WB "Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril." Arch Intern Med 146 (1986): 1833-4. [PMID: 3530167]
212	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
213	Product Information. Cialis (tadalafil). Lilly, Eli and Company, Indianapolis, IN.
214	Product Information. Stendra (avanafil). Vivus Inc, Mountain View, CA.
215	Baba T, Tomiyama T, Takebe K "Enhancement by an ACE inhibitor of first-dose hypotension caused by an alpha-blocker." N Engl J Med 322 (1990): 1237. [PMID: 1970122]
216	Cohen J "Long-term efficacy and safety of terazosin alone and in combination with other antihypertensive agents." Am Heart J 122 (1991): 919-25. [PMID: 1678923]
217	Product Information. Jardiance (empagliflozin). Boehringer Ingelheim, Ridgefield, CT.
218	Product Information. Lamprene (clofazimine). Novartis Pharmaceuticals, East Hanover, NJ.
219	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
220	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
221	Skerjanec A, Wang J, Maren K, Rojkjaer L "Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers." J Clin Pharmacol 50 (2010): 205-13. [PMID: 19940232]
222	Product Information. Austedo (deutetrabenazine). Teva Pharmaceuticals USA, North Wales, PA.
223	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
224	Product Information. Precedex (dexmedetomidine) Abbott Pharmaceutical, Abbott Park, IL.
225	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
226	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
227	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
228	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
229	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
230	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
231	Product Information. Flolan (epoprostenol). Glaxo Wellcome, Research Triangle Park, NC.
232	Product Information. Remodulin (treprostinil). United Therapeutics Corp, Silver Spring, MD.
233	Kawano Y, Abe H, Kojima S, Takishita S, Omae T "Interaction of alcohol and an a1-blocker on ambulatory blood pressure in patients with essential hypertension." Am J Hypertens 13 (2000): 307-12
234	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
235	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
236	Product Information. Corlopam (fenoldopam). Neurex, Menlo Park, CA.
237	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
238	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
239	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
240	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
241	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
242	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
243	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
244	Product Information. Tenex (guanfacine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
245	Product Information. Besponsa (inotuzumab ozogamicin). Wyeth Laboratories, Philadelphia, PA.
246	Ban TA "Drug interactions with psychoactive drugs." Dis Nerv Syst 36 (1975): 164-6. [PMID: 1116424]
247	De Vita VT, Hahn MA, Oliverio VT "Monoamine oxidase inhibition by a new carcinostatic agent, n-isopropyl-a-(2-methylhydrazino)-p-toluamide (MIH). (30590)." Proc Soc Exp Biol Med 120 (1965): 561-5. [PMID: 4379192]
248	Goldberg LI "Monoamine oxidase inhibitors: adverse reactions and possible mechanisms." JAMA 190 (1964): 456-62. [PMID: 14197995]
249	Golwyn DH, Sevlie CP "Monoamine oxidase inhibitor hypertensive crisis headache and orthostatic hypotension." J Clin Psychopharmacol 13 (1993): 77-8. [PMID: 8486823]
250	Kronig MH, Roose SP, Walsh BT, Woodring S, Glassman AH "Blood pressure effects of phenelzine." J Clin Psychopharmacol 3 (1983): 307-10. [PMID: 6630590]
251	Pettinger WA, Soyangco FG, Oates JA "Inhibition of monoamine oxidase in man by furazolidone." Clin Pharmacol Ther 9 (1968): 442-7. [PMID: 5655478]
252	Product Information. Marplan (isocarboxazid) Roche Laboratories, Nutley, NJ.
253	Product Information. Matulane (procarbazine). Roche Laboratories, Nutley, NJ.
254	Product Information. Nardil (phenelzine). Parke-Dvis, Morris Plains, NJ.
255	Product Information. Parnate (tranylcypromine). SmithKline Beecham, Philadelphia, PA.
256	Reggev A, Vollhardt BR "Bradycardia induced by an interaction between phenelzine and beta blockers." Psychosomatics 30 (1992): 106-8. [PMID: 2913594]
257	Schulz R, Antonin KH, Hoffmann E, et al "Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline." Clin Pharmacol Ther 46 (1989): 528-36. [PMID: 2510962]
258	Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
259	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
260	Ho PC, Ghose K, Saville D, Wanwimolruk S "Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers." Eur J Clin Pharmacol 56 (2000): 693-8. [PMID: 11214778]
261	Product Information. Stalevo 150 (carbidopa/entacapone/levodopa). Novartis Pharmaceuticals, East Hanover, NJ.
262	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs. Prolongation of QT interval is probably a class effect of fluoroquinolones." Br Med J 322 (2001): 46-7. [PMID: 11141163]
263	Kahn JB "Latest industry information on the safety profile of levofloxacin in the US." Chemotherapy 47 Suppl 3 (2001): 32-7. [PMID: 11549787]
264	Makaryus AN, Byrns K, Makaryus MN, Natarajan U, Singer C, Goldner B "Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?" South Med J 99 (2006): 52-6. [PMID: 16466123]
265	Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG "QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine." Ann Pharmacother 39 (2005): 543-6. [PMID: 15687478]
266	Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
267	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
268	Samaha FF "QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin." Am J Med 107 (1999): 528-9. [PMID: 10569314]
269	Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR "Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age." Lancet 2 (1987): 821-4. [PMID: 2889032]
270	Cumming AM "Metabolic effects of licorice." Br Med J 1 (1977): 906
271	Epstein MT, Espiner EA, Donald RA, Hughes H "Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects." Br Med J 1 (1977): 488-90
272	Product Information. Lucemyra (lofexidine). US WorldMeds LLC, Louisville , KY.
273	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
274	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
275	Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
276	Product Information. Selzentry (maraviroc). Pfizer U.S. Pharmaceuticals Group, New York, NY.
277	Leenen FH, Smith DL, Unger WP "Topical minoxidil: cardiac effects in bald men." Br J Clin Pharmacol 26 (1988): 481-5. [PMID: 3191000]
278	Product Information. Rogaine (minoxidil topical). Johnson and Johnson/McNeil Consumer, Fort Washington, PA.
279	Jee LD, Opie LH "Acute hypotensive response to nifedipine added to prazosin in treatment of hypertension." Br Med J 287 (1983): 1514
280	Fuhr U, Maier-Bruggemann A, Blume H, et al. "Grapefruit juice increases oral nimodipine bioavailability." Int J Clin Pharmacol Ther 36 (1998): 126-32. [PMID: 9562227]
281	Gunston GD, Mehta U "Potentially serious drug interactions with grapefruit juice." S Afr Med J 90 (2000): 41. [PMID: 10721388]
282	Product Information. Sodium Nitrite (sodium nitrite). Hope Pharmaceuticals, Scottsdale, AZ.
283	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
284	Product Information. Patanase (olopatadine nasal). Alcon Laboratories Inc, Fort Worth, TX.
285	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
286	Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
287	Product Information. Trental (pentoxifylline). Hoechst Marion-Roussel Inc, Kansas City, MO.
288	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
289	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
290	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
291	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
292	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
293	Product Information. Wakix (pitolisant). Harmony Biosciences, LLC, Plymouth Meeting, PA.
294	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
295	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
296	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
297	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
298	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
299	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
300	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
301	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
302	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
303	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
304	Product Information. Allegra-D (fexofenadine-pseudoephedrine). Chattem Consumer Products, Chattanooga, TN.
305	Product Information. Priftin (rifapentine). Hoechst Marion-Roussel Inc, Kansas City, MO.
306	Thijssen HH, Flin ois JP, Beaune PH "Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes." Drug Metab Dispos 28 (2000): 1284-90. [PMID: 11038154]
307	Product Information. Adempas (riociguat). Bayer Pharmaceutical Inc, West Haven, CT.
308	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
309	Product Information. Adcirca (tadalafil). United Therapeutics Corporation, Silver Spring, MD.
310	Product Information. Rapaflo (silodosin). Watson Pharmaceuticals, Corona, CA.
311	Product Information. Xenazine (tetrabenazine). Prestwick Pharmaceuticals Inc, Washington DC, VA.
312	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
313	Product Information. Zanaflex (tizanidine). Acorda Therapeutics, Hawthorne, NY.
314	Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]
315	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
316	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
317	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
318	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
319	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
320	Product Information. Ingrezza (valbenazine). Neurocrine Biosciences, Inc., San Diego, CA.
321	Product Information. Levitra (vardenafil). Bayer, West Haven, CT.
322	McTavish D, Sorkin EM "Verapamil: an updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension." Drugs 38 (1989): 19-76. [PMID: 2670511]
323	Pasanisi F, Elliot HL, Meredith PA, McSharry DR, Reid JL "Combined alpha adrenoceptor antagonism and calcium channel blockage in normal subjects." Clin Pharmacol Ther 36 (1984): 716-23
324	Kiss I, Farsang C "Nifedipine-prazosin interaction in patients with essential hypertension." Cardiovasc Drugs Ther 3 (1989): 413-5
325	Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
326	Sigusch H, Henschel L, Kraul H, Merkel U, Hoffmann A "Lack of effect of grapefruit juice on diltiazem bioavailability in normal subjects." Pharmazie 49 (1994): 675-9.[PMID: 7972311]
327	Christensen H, Asberg A, Holmboe AB, Berg KJ "Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers." Eur J Clin Pharmacol 58 (2002): 515-520.[PMID: 12451428]
328	Product Information. ProAmatine (midodrine). Roberts Pharmaceutical Corporation, Eatontown, NJ.
329	European Medicines Agency "CHMP Assessment Report for Latixa. International nonproprietary name: ranolazine.".
330	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
331	Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
332	Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
333	Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
334	Robertson P Jr, Hellriegel ET, Arora S, Nelson M "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers." Clin Pharmacol Ther 71 (2002): 46-56. [PMID: 11823757]
335	Robertson P, Decory HH, Madan A, Parkinson A "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil." Drug Metab Dispos 28 (2000): 664-71. [PMID: 10820139]
336	Tattelman E "Health effects of garlic." Am Fam Physician 72 (2005): 103-6
337	Richard CL, Jurgens TM "Effects of natural health products on blood pressure." Ann Pharmacother 39 (2005): 712-20
338	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
339	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
340	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
341	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
342	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
343	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
344	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence